•
Suzhou Leadsynbio Technology Co., Ltd, a specialist in synthetic biology, has reported raised hundreds of millions of dollars of renminbi in a Series D finance round. The round was backed by existing investors Lily Asia Ventures and Sherpa Healthcare Partners. The proceedings from this funding will be allocated to bolder…